Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06458790 · ClinicalTrials.gov registry record · NA
Black Resilient Caregivers
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 44
- Enrollment target
NCT06458790: Completed NA study, sponsored by Duke University.
NCT06458790 is a NA study that has completed, run by Duke University. The registered enrollment target is 44 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06458790, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
Study Summary
To determine the feasibility of an intervention to promote the physical and socioemotional health of African American (AA) families.
Primary Outcome
Acceptability of Intervention Measure (modified) uses the following scale: Completely disagree / Disagree / Neither agree nor disagree / Agree / Completely agree. The more participants agree or completely agree, the better the outcome.
Interventions
- BEHAVIORAL AARC
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2024-09-20 |
| Est. Completion | 2025-11-25 |
| Phase | NA |
What the finished NCT06458790 record still lists
NCT06458790 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which AARC is the first listed.
NCT06458790 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06458790 about?
NCT06458790 is a clinical study titled "Black Resilient Caregivers". To determine the feasibility of an intervention to promote the physical and socioemotional health of African American (AA) families.
What is the current status of trial NCT06458790?
This trial is currently completed. It is a NA study. The enrollment target is 44 participants. The study started on 2024-09-20. Estimated completion is 2025-11-25.
What interventions are being tested in trial NCT06458790?
The interventions under investigation include: AARC (BEHAVIORAL).
Who is sponsoring clinical trial NCT06458790?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06458790's enrollment target sits among peer trials
44 1423rd of 2000 higher than 566 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI